Keywords: Tumors, BrainThis project intends to innovatively design and synthesize novel radiotherapy sensitization and enhanced CDT dual-effect sensitization nanodrugs, further wrap them with engineered red blood cell membrane vesicles, and construct a high-performance biomimetic nanomedicine synergistic treatment system with high targeting, high specificity and high yield of reactive oxygen species, in order to achieve the specificity and high efficiency accumulation of nanomedicines in the GBM, while reducing toxicity to normal tissues. Magnetic resonance and other imaging methods are used to guide the efficient treatment of drugs and monitor the effect of tumor ablation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords